Bladder Cancer Clinical Trial

Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer

Summary

A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely to have serious side effects from cancer treatment. However, it is unknown whether interventions can be done to address the impairments found during a CGA in order to reduce the risk of these side effects. This pilot study will test the feasibility of targeted interventions for deficits identified during a CGA in patients 65 years or older with bladder cancer that have not yet started treatment.

View Full Description

Full Description

This study will enroll patients with muscle-invasive bladder cancer that have not yet started systemic cancer treatment. The participants will complete a CGA and patient-reported outcome (PRO) measures at baseline. Based on any impairments found during the CGA, participants will be referred to specialists to help address these difficulties. Participants will complete the CGA and PRO measures again at 3 months and 1 year after the initial assessment. The goal of this study is to see if patients with advanced bladder cancer are interested in referrals to specialists to address their impairments, and whether participants attend those appointments.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 65 years or older
Confirmed diagnosis of muscle-invasive bladder cancer
Plan to undergo systemic treatment but have not yet started therapy

Exclusion Criteria:

Must be able to read English

Study is for people with:

Bladder Cancer

Estimated Enrollment:

5

Study ID:

NCT04273724

Recruitment Status:

Terminated

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill North Carolina, 27599, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

5

Study ID:

NCT04273724

Recruitment Status:

Terminated

Sponsor:


UNC Lineberger Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider